Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease

Journal of Neurology
Joan DuprezPaul Sauleau

Abstract

Continuous subcutaneous apomorphine infusion (CSAI) is increasingly used in Parkinson's disease (PD), notably in patients contraindicated for subthalamic deep brain stimulation. Although it has been suggested that CSAI is safe regarding cognition, few studies have actually investigated its effect, especially on cognitive control which is a crucial process for goal-directed behavior. More specifically, its impact on the dynamics of cognitive action control, as reflected by the activation and suppression of impulsive responses, has yet to be investigated, which is the objective of the present study. We compared cognitive action control between baseline (M0) and 6 months (M6) after the start of add-on CSAI by administering an oculomotor Simon task to 20 patients with mild to moderate PD. We used the activation-suppression model to determine whether CSAI had an effect on either the impulsive errors made in conflict situations or the suppression of these responses. We found no difference between M0 and M6 in the congruence effect regarding either reaction time or accuracy, indicating that overall conflict resolution was not influenced by CSAI. Furthermore, the rate of fast errors in the conflict situation and the last slope of the d...Continue Reading

References

Jul 1, 1969·Journal of Experimental Psychology·J R Simon
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Aug 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·E RůzickaR Jech
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Montse AlegretEduardo Tolosa
Aug 26, 2009·Journal of Cognitive Neuroscience·Scott A WylieWery P M van den Wildenberg
Sep 24, 2010·Brain : a Journal of Neurology·Scott A WylieWery P M van den Wildenberg
Dec 24, 2010·Frontiers in Human Neuroscience·Wery P M van den WildenbergK Richard Ridderinkhof
Sep 6, 2011·Parkinsonism & Related Disorders·Sophie DrapierMarc Vérin
May 9, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Samo Ribarič
May 11, 2012·Journal of Cognitive Neuroscience·Scott A WylieWery P M van den Wildenberg
Aug 25, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Scott A WylieCarol A Manning
Mar 1, 2011·Wiley Interdisciplinary Reviews. Cognitive Science·K Richard RidderinkhofWery P M van den Wildenberg
Nov 9, 2016·Frontiers in Aging Neuroscience·Joan DuprezPaul Sauleau
Dec 13, 2016·Parkinsonism & Related Disorders·Miguel Rosa-GriloK Ray Chaudhuri
Jan 1, 2017·Neuropsychologia·Joan DuprezPaul Sauleau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.